China Resources Pharmaceutical Group CR Pharma has launched its Hong Kong initial public offering. The transaction has been eagerly awaited by investors because of its size and analyst expectations that the listed stock should perform better than other recent IPOs.
On Thursday the pharmaceutical arm of China Resources Holdings started bookbuilding for the transaction, which could raise as much as $1.57 billion $2 billion pre-greenshoe and $2.32 billion post-greenshoe.
Other billion-dollar IPOs in Hong Kong this year have not fared well. Postal Savings Bank of China, China Zheshang Bank and BOC Aviation have largely underperformed the broader market since...
¬ Haymarket Media Limited. All rights reserved.
